Prime Medicine PRME Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prime Medicine's short- and long-term operating lease liabilities?
- Prime Medicine (PRME) reported short- and long-term operating lease liabilities of -$1.92M in Q1 2026.
- How has Prime Medicine's short- and long-term operating lease liabilities changed year-over-year?
- Prime Medicine's short- and long-term operating lease liabilities decreased by 200.2% year-over-year, from -$638K to -$1.92M.
- What is the long-term trend for Prime Medicine's short- and long-term operating lease liabilities?
- Over 3 years (2022 to 2025), Prime Medicine's short- and long-term operating lease liabilities has grown at a -19.4% compound annual growth rate (CAGR), from -$10.25M to -$5.36M.